Global and United States Benign Prostatic Hyperplasia Treatment Market Report & Forecast 2023-2028

Report ID: 1788850 | Published Date: Jan 2025 | No. of Page: 108 | Base Year: 2024 | Rating: 5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Benign Prostatic Hyperplasia Treatment Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Benign Prostatic Hyperplasia Treatment Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Benign Prostatic Hyperplasia Treatment Market Size for the Year 2017-2028
        1.2.2 Global Benign Prostatic Hyperplasia Treatment Market Size for the Year 2017-2028
    1.3 Benign Prostatic Hyperplasia Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Benign Prostatic Hyperplasia Treatment in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Benign Prostatic Hyperplasia Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Benign Prostatic Hyperplasia Treatment Market Dynamics
        1.4.1 Benign Prostatic Hyperplasia Treatment Industry Trends
        1.4.2 Benign Prostatic Hyperplasia Treatment Market Drivers
        1.4.3 Benign Prostatic Hyperplasia Treatment Market Challenges
        1.4.4 Benign Prostatic Hyperplasia Treatment Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Benign Prostatic Hyperplasia Treatment by Type
    2.1 Benign Prostatic Hyperplasia Treatment Market Segment by Type
        2.1.1 Drug Class
        2.1.2 Minimally Invasive Surgeries
        2.1.3 Laser Therapy
        2.1.4 Others
    2.2 Global Benign Prostatic Hyperplasia Treatment Market Size by Type (2017, 2022 & 2028)
    2.3 Global Benign Prostatic Hyperplasia Treatment Market Size by Type (2017-2028)
    2.4 United States Benign Prostatic Hyperplasia Treatment Market Size by Type (2017, 2022 & 2028)
    2.5 United States Benign Prostatic Hyperplasia Treatment Market Size by Type (2017-2028)
3 Benign Prostatic Hyperplasia Treatment by Application
    3.1 Benign Prostatic Hyperplasia Treatment Market Segment by Application
        3.1.1 Hospitals
        3.1.2 Ambulatory Surgical Centers
        3.1.3 Specialty Clinics
        3.1.4 Others
    3.2 Global Benign Prostatic Hyperplasia Treatment Market Size by Application (2017, 2022 & 2028)
    3.3 Global Benign Prostatic Hyperplasia Treatment Market Size by Application (2017-2028)
    3.4 United States Benign Prostatic Hyperplasia Treatment Market Size by Application (2017, 2022 & 2028)
    3.5 United States Benign Prostatic Hyperplasia Treatment Market Size by Application (2017-2028)
4 Global Benign Prostatic Hyperplasia Treatment Competitor Landscape by Company
    4.1 Global Benign Prostatic Hyperplasia Treatment Market Size by Company
        4.1.1 Top Global Benign Prostatic Hyperplasia Treatment Companies Ranked by Revenue (2021)
        4.1.2 Global Benign Prostatic Hyperplasia Treatment Revenue by Player (2017-2022)
    4.2 Global Benign Prostatic Hyperplasia Treatment Concentration Ratio (CR)
        4.2.1 Benign Prostatic Hyperplasia Treatment Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Benign Prostatic Hyperplasia Treatment in 2021
        4.2.3 Global Benign Prostatic Hyperplasia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Benign Prostatic Hyperplasia Treatment Headquarters, Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Benign Prostatic Hyperplasia Treatment Headquarters and Area Served
        4.3.2 Global Benign Prostatic Hyperplasia Treatment Companies Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Benign Prostatic Hyperplasia Treatment Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Benign Prostatic Hyperplasia Treatment Market Size by Company
        4.5.1 Top Benign Prostatic Hyperplasia Treatment Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Benign Prostatic Hyperplasia Treatment Revenue by Players (2020, 2021 & 2022)
5 Global Benign Prostatic Hyperplasia Treatment Market Size by Region
    5.1 Global Benign Prostatic Hyperplasia Treatment Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Benign Prostatic Hyperplasia Treatment Market Size by Region (2017-2028)
        5.2.1 Global Benign Prostatic Hyperplasia Treatment Market Size by Region: 2017-2022
        5.2.2 Global Benign Prostatic Hyperplasia Treatment Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Benign Prostatic Hyperplasia Treatment Market Size YoY Growth 2017-2028
        6.1.2 North America Benign Prostatic Hyperplasia Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Benign Prostatic Hyperplasia Treatment Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Benign Prostatic Hyperplasia Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Benign Prostatic Hyperplasia Treatment Market Size YoY Growth 2017-2028
        6.3.2 Europe Benign Prostatic Hyperplasia Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Benign Prostatic Hyperplasia Treatment Market Size YoY Growth 2017-2028
        6.4.2 Latin America Benign Prostatic Hyperplasia Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Benign Prostatic Hyperplasia Treatment Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Benign Prostatic Hyperplasia Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 Abbott
        7.1.1 Abbott Company Details
        7.1.2 Abbott Business Overview
        7.1.3 Abbott Benign Prostatic Hyperplasia Treatment Introduction
        7.1.4 Abbott Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
        7.1.5 Abbott Recent Development
    7.2 Allergan plc
        7.2.1 Allergan plc Company Details
        7.2.2 Allergan plc Business Overview
        7.2.3 Allergan plc Benign Prostatic Hyperplasia Treatment Introduction
        7.2.4 Allergan plc Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
        7.2.5 Allergan plc Recent Development
    7.3 Astellas Pharma
        7.3.1 Astellas Pharma Company Details
        7.3.2 Astellas Pharma Business Overview
        7.3.3 Astellas Pharma Benign Prostatic Hyperplasia Treatment Introduction
        7.3.4 Astellas Pharma Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
        7.3.5 Astellas Pharma Recent Development
    7.4 Asahi Kasei Corporation
        7.4.1 Asahi Kasei Corporation Company Details
        7.4.2 Asahi Kasei Corporation Business Overview
        7.4.3 Asahi Kasei Corporation Benign Prostatic Hyperplasia Treatment Introduction
        7.4.4 Asahi Kasei Corporation Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
        7.4.5 Asahi Kasei Corporation Recent Development
    7.5 Boehringer Ingelheim GmbH
        7.5.1 Boehringer Ingelheim GmbH Company Details
        7.5.2 Boehringer Ingelheim GmbH Business Overview
        7.5.3 Boehringer Ingelheim GmbH Benign Prostatic Hyperplasia Treatment Introduction
        7.5.4 Boehringer Ingelheim GmbH Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
        7.5.5 Boehringer Ingelheim GmbH Recent Development
    7.6 GlaxoSmithKline
        7.6.1 GlaxoSmithKline Company Details
        7.6.2 GlaxoSmithKline Business Overview
        7.6.3 GlaxoSmithKline Benign Prostatic Hyperplasia Treatment Introduction
        7.6.4 GlaxoSmithKline Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
        7.6.5 GlaxoSmithKline Recent Development
    7.7 Pfizer
        7.7.1 Pfizer Company Details
        7.7.2 Pfizer Business Overview
        7.7.3 Pfizer Benign Prostatic Hyperplasia Treatment Introduction
        7.7.4 Pfizer Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
        7.7.5 Pfizer Recent Development
    7.8 Sanofi
        7.8.1 Sanofi Company Details
        7.8.2 Sanofi Business Overview
        7.8.3 Sanofi Benign Prostatic Hyperplasia Treatment Introduction
        7.8.4 Sanofi Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
        7.8.5 Sanofi Recent Development
    7.9 Teva Pharmaceutical Industries
        7.9.1 Teva Pharmaceutical Industries Company Details
        7.9.2 Teva Pharmaceutical Industries Business Overview
        7.9.3 Teva Pharmaceutical Industries Benign Prostatic Hyperplasia Treatment Introduction
        7.9.4 Teva Pharmaceutical Industries Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
        7.9.5 Teva Pharmaceutical Industries Recent Development
    7.10 Merck
        7.10.1 Merck Company Details
        7.10.2 Merck Business Overview
        7.10.3 Merck Benign Prostatic Hyperplasia Treatment Introduction
        7.10.4 Merck Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
        7.10.5 Merck Recent Development
    7.11 Boston Scientific Corporation
        7.11.1 Boston Scientific Corporation Company Details
        7.11.2 Boston Scientific Corporation Business Overview
        7.11.3 Boston Scientific Corporation Benign Prostatic Hyperplasia Treatment Introduction
        7.11.4 Boston Scientific Corporation Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
        7.11.5 Boston Scientific Corporation Recent Development
    7.12 Teleflex Incorporated
        7.12.1 Teleflex Incorporated Company Details
        7.12.2 Teleflex Incorporated Business Overview
        7.12.3 Teleflex Incorporated Benign Prostatic Hyperplasia Treatment Introduction
        7.12.4 Teleflex Incorporated Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
        7.12.5 Teleflex Incorporated Recent Development
    7.13 Endo International
        7.13.1 Endo International Company Details
        7.13.2 Endo International Business Overview
        7.13.3 Endo International Benign Prostatic Hyperplasia Treatment Introduction
        7.13.4 Endo International Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
        7.13.5 Endo International Recent Development
    7.14 Urologix
        7.14.1 Urologix Company Details
        7.14.2 Urologix Business Overview
        7.14.3 Urologix Benign Prostatic Hyperplasia Treatment Introduction
        7.14.4 Urologix Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
        7.14.5 Urologix Recent Development
    7.15 LISA Laser
        7.15.1 LISA Laser Company Details
        7.15.2 LISA Laser Business Overview
        7.15.3 LISA Laser Benign Prostatic Hyperplasia Treatment Introduction
        7.15.4 LISA Laser Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
        7.15.5 LISA Laser Recent Development
    7.16 Olympus
        7.16.1 Olympus Company Details
        7.16.2 Olympus Business Overview
        7.16.3 Olympus Benign Prostatic Hyperplasia Treatment Introduction
        7.16.4 Olympus Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
        7.16.5 Olympus Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer
List of Tables
    Table 1. Benign Prostatic Hyperplasia Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Benign Prostatic Hyperplasia Treatment Market Trends
    Table 3. Benign Prostatic Hyperplasia Treatment Market Drivers
    Table 4. Benign Prostatic Hyperplasia Treatment Market Challenges
    Table 5. Benign Prostatic Hyperplasia Treatment Market Restraints
    Table 6. Global Benign Prostatic Hyperplasia Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Benign Prostatic Hyperplasia Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Benign Prostatic Hyperplasia Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Benign Prostatic Hyperplasia Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Benign Prostatic Hyperplasia Treatment Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Benign Prostatic Hyperplasia Treatment Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Benign Prostatic Hyperplasia Treatment Revenue Share by Player, 2017-2022
    Table 13. Global Benign Prostatic Hyperplasia Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Benign Prostatic Hyperplasia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Benign Prostatic Hyperplasia Treatment as of 2021)
    Table 15. Top Players of Benign Prostatic Hyperplasia Treatment in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Benign Prostatic Hyperplasia Treatment Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Benign Prostatic Hyperplasia Treatment Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Benign Prostatic Hyperplasia Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Benign Prostatic Hyperplasia Treatment Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Benign Prostatic Hyperplasia Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Benign Prostatic Hyperplasia Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Benign Prostatic Hyperplasia Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Benign Prostatic Hyperplasia Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Benign Prostatic Hyperplasia Treatment Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Benign Prostatic Hyperplasia Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Benign Prostatic Hyperplasia Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Benign Prostatic Hyperplasia Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. Abbott Company Details
    Table 31. Abbott Business Overview
    Table 32. Abbott Benign Prostatic Hyperplasia Treatment Product
    Table 33. Abbott Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022) & (US$ Million)
    Table 34. Abbott Recent Development
    Table 35. Allergan plc Company Details
    Table 36. Allergan plc Business Overview
    Table 37. Allergan plc Benign Prostatic Hyperplasia Treatment Product
    Table 38. Allergan plc Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022) & (US$ Million)
    Table 39. Allergan plc Recent Development
    Table 40. Astellas Pharma Company Details
    Table 41. Astellas Pharma Business Overview
    Table 42. Astellas Pharma Benign Prostatic Hyperplasia Treatment Product
    Table 43. Astellas Pharma Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022) & (US$ Million)
    Table 44. Astellas Pharma Recent Development
    Table 45. Asahi Kasei Corporation Company Details
    Table 46. Asahi Kasei Corporation Business Overview
    Table 47. Asahi Kasei Corporation Benign Prostatic Hyperplasia Treatment Product
    Table 48. Asahi Kasei Corporation Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022) & (US$ Million)
    Table 49. Asahi Kasei Corporation Recent Development
    Table 50. Boehringer Ingelheim GmbH Company Details
    Table 51. Boehringer Ingelheim GmbH Business Overview
    Table 52. Boehringer Ingelheim GmbH Benign Prostatic Hyperplasia Treatment Product
    Table 53. Boehringer Ingelheim GmbH Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022) & (US$ Million)
    Table 54. Boehringer Ingelheim GmbH Recent Development
    Table 55. GlaxoSmithKline Company Details
    Table 56. GlaxoSmithKline Business Overview
    Table 57. GlaxoSmithKline Benign Prostatic Hyperplasia Treatment Product
    Table 58. GlaxoSmithKline Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022) & (US$ Million)
    Table 59. GlaxoSmithKline Recent Development
    Table 60. Pfizer Company Details
    Table 61. Pfizer Business Overview
    Table 62. Pfizer Benign Prostatic Hyperplasia Treatment Product
    Table 63. Pfizer Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022) & (US$ Million)
    Table 64. Pfizer Recent Development
    Table 65. Sanofi Company Details
    Table 66. Sanofi Business Overview
    Table 67. Sanofi Benign Prostatic Hyperplasia Treatment Product
    Table 68. Sanofi Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022) & (US$ Million)
    Table 69. Sanofi Recent Development
    Table 70. Teva Pharmaceutical Industries Company Details
    Table 71. Teva Pharmaceutical Industries Business Overview
    Table 72. Teva Pharmaceutical Industries Benign Prostatic Hyperplasia Treatment Product
    Table 73. Teva Pharmaceutical Industries Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022) & (US$ Million)
    Table 74. Teva Pharmaceutical Industries Recent Development
    Table 75. Merck Company Details
    Table 76. Merck Business Overview
    Table 77. Merck Benign Prostatic Hyperplasia Treatment Product
    Table 78. Merck Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022) & (US$ Million)
    Table 79. Merck Recent Development
    Table 80. Boston Scientific Corporation Company Details
    Table 81. Boston Scientific Corporation Business Overview
    Table 82. Boston Scientific Corporation Benign Prostatic Hyperplasia Treatment Product
    Table 83. Boston Scientific Corporation Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022) & (US$ Million)
    Table 84. Boston Scientific Corporation Recent Development
    Table 85. Teleflex Incorporated Company Details
    Table 86. Teleflex Incorporated Business Overview
    Table 87. Teleflex Incorporated Benign Prostatic Hyperplasia Treatment Product
    Table 88. Teleflex Incorporated Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022) & (US$ Million)
    Table 89. Teleflex Incorporated Recent Development
    Table 90. Endo International Company Details
    Table 91. Endo International Business Overview
    Table 92. Endo International Benign Prostatic Hyperplasia Treatment Product
    Table 93. Endo International Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022) & (US$ Million)
    Table 94. Endo International Recent Development
    Table 95. Urologix Company Details
    Table 96. Urologix Business Overview
    Table 97. Urologix Benign Prostatic Hyperplasia Treatment Product
    Table 98. Urologix Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022) & (US$ Million)
    Table 99. Urologix Recent Development
    Table 100. LISA Laser Company Details
    Table 101. LISA Laser Business Overview
    Table 102. LISA Laser Benign Prostatic Hyperplasia Treatment Product
    Table 103. LISA Laser Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022) & (US$ Million)
    Table 104. LISA Laser Recent Development
    Table 105. Olympus Company Details
    Table 106. Olympus Business Overview
    Table 107. Olympus Benign Prostatic Hyperplasia Treatment Product
    Table 108. Olympus Revenue in Benign Prostatic Hyperplasia Treatment Business (2017-2022) & (US$ Million)
    Table 109. Olympus Recent Development
    Table 110. Research Programs/Design for This Report
    Table 111. Key Data Information from Secondary Sources
    Table 112. Key Data Information from Primary Sources
List of Figures
    Figure 1. Benign Prostatic Hyperplasia Treatment Product Picture
    Figure 2. Global Benign Prostatic Hyperplasia Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Benign Prostatic Hyperplasia Treatment Market Size 2017-2028 (US$ Million)
    Figure 4. United States Benign Prostatic Hyperplasia Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Benign Prostatic Hyperplasia Treatment Market Size 2017-2028 (US$ Million)
    Figure 6. United States Benign Prostatic Hyperplasia Treatment Market Share in Global 2017-2028
    Figure 7. Benign Prostatic Hyperplasia Treatment Report Years Considered
    Figure 8. Product Picture of Drug Class
    Figure 9. Product Picture of Minimally Invasive Surgeries
    Figure 10. Product Picture of Laser Therapy
    Figure 11. Product Picture of Others
    Figure 12. Global Benign Prostatic Hyperplasia Treatment Market Share by Type in 2022 & 2028
    Figure 13. Global Benign Prostatic Hyperplasia Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 14. Global Benign Prostatic Hyperplasia Treatment Market Share by Type (2017-2028)
    Figure 15. United States Benign Prostatic Hyperplasia Treatment Market Share by Type in 2022 & 2028
    Figure 16. United States Benign Prostatic Hyperplasia Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 17. United States Benign Prostatic Hyperplasia Treatment Market Share by Type (2017-2028)
    Figure 18. Product Picture of Hospitals
    Figure 19. Product Picture of Ambulatory Surgical Centers
    Figure 20. Product Picture of Specialty Clinics
    Figure 21. Product Picture of Others
    Figure 22. Global Benign Prostatic Hyperplasia Treatment Market Share by Application in 2022 & 2028
    Figure 23. Global Benign Prostatic Hyperplasia Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. Global Benign Prostatic Hyperplasia Treatment Market Share by Application (2017-2028)
    Figure 25. United States Benign Prostatic Hyperplasia Treatment Market Share by Application in 2022 & 2028
    Figure 26. United States Benign Prostatic Hyperplasia Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 27. United States Benign Prostatic Hyperplasia Treatment Market Share by Application (2017-2028)
    Figure 28. North America Benign Prostatic Hyperplasia Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. U.S. Benign Prostatic Hyperplasia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. Canada Benign Prostatic Hyperplasia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. Europe Benign Prostatic Hyperplasia Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 32. Germany Benign Prostatic Hyperplasia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. France Benign Prostatic Hyperplasia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. U.K. Benign Prostatic Hyperplasia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 35. Italy Benign Prostatic Hyperplasia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Russia Benign Prostatic Hyperplasia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. Asia-Pacific Benign Prostatic Hyperplasia Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 38. China Benign Prostatic Hyperplasia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Japan Benign Prostatic Hyperplasia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. South Korea Benign Prostatic Hyperplasia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. India Benign Prostatic Hyperplasia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Australia Benign Prostatic Hyperplasia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Taiwan Benign Prostatic Hyperplasia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Indonesia Benign Prostatic Hyperplasia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Thailand Benign Prostatic Hyperplasia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 46. Malaysia Benign Prostatic Hyperplasia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Philippines Benign Prostatic Hyperplasia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Latin America Benign Prostatic Hyperplasia Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 49. Mexico Benign Prostatic Hyperplasia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 50. Brazil Benign Prostatic Hyperplasia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Argentina Benign Prostatic Hyperplasia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. Middle East & Africa Benign Prostatic Hyperplasia Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 53. Turkey Benign Prostatic Hyperplasia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Benign Prostatic Hyperplasia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 55. U.A.E Benign Prostatic Hyperplasia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 56. Abbott Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
    Figure 57. Allergan plc Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
    Figure 58. Astellas Pharma Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
    Figure 59. Asahi Kasei Corporation Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
    Figure 60. Boehringer Ingelheim GmbH Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
    Figure 61. GlaxoSmithKline Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
    Figure 62. Pfizer Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
    Figure 63. Sanofi Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
    Figure 64. Teva Pharmaceutical Industries Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
    Figure 65. Merck Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
    Figure 66. Boston Scientific Corporation Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
    Figure 67. Teleflex Incorporated Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
    Figure 68. Endo International Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
    Figure 69. Urologix Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
    Figure 70. LISA Laser Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
    Figure 71. Olympus Revenue Growth Rate in Benign Prostatic Hyperplasia Treatment Business (2017-2022)
    Figure 72. Bottom-up and Top-down Approaches for This Report
    Figure 73. Data Triangulation
    Figure 74. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Abbott
Allergan plc
Astellas Pharma
Asahi Kasei Corporation
Boehringer Ingelheim GmbH
GlaxoSmithKline
Pfizer
Sanofi
Teva Pharmaceutical Industries
Merck
Boston Scientific Corporation
Teleflex Incorporated
Endo International
Urologix
LISA Laser
Olympus
Frequently Asked Questions
Benign Prostatic Hyperplasia Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Benign Prostatic Hyperplasia Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Benign Prostatic Hyperplasia Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Meat Mixer

Meat Mixer market is segmented by region (country), players, by Type and by Application. Players, ... Read More